Highlights AstraZeneca PLC

Equities

Market Closed - London S.E. Other stock markets 09:05:07 08/05/2024 pm IST			5-day change	1st Jan Change
12,264 ^GBX	+1.20%		+1.67%	+15.70%

08/05	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	MT
08/05	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	MT

AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	09/05	MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	09/05	MT
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	08/05	MT
AstraZeneca, Merck Sue Over Cancer Drug Patent Infringement	08/05	MT
AstraZeneca to Reportedly Withdraw COVID-19 Vaccine Amid Cooling Demand	08/05	MT
AstraZeneca says withdraws Covid vaccine "for commercial reasons"	08/05	AN
AstraZeneca lifts FTSE 100 to record high; BOE rate decision on tap	08/05	RE
AstraZeneca to Remove COVID-19 Jab from EU Markets Due to Commercial Reasons	08/05	MT
AstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports	08/05	RE
AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports	08/05	RE
The Oxford-Astrazeneca COVID Vaccine Is Being Withdrawn Worldwide- The Telegraph	08/05	RE
THE OXFORD-ASTRAZENECA COVID VACCINE IS BEING WITHDRAWN WORL…	08/05	RE
BP starts USD1.75 billion share buyback scheme	07/05	AN
Cellectis: alliance with AstraZeneca finalized	06/05	CF
Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca	06/05	MT
AstraZeneca: equity investment in Cellectis	06/05	CF
AstraZeneca completes collaboration and investment deal with Cellectis	06/05	AN
AstraZeneca Secures 44% Stake in French Biotech Cellectis	06/05	MT
Angle shares up on assay development deal with AstraZeneca	03/05	AN
Angle shares up on assay development deal with AstraZenaca	03/05	AN

No results for this search

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 09:32 pm IST